Kopran acquires assets of API manufacturing facility of Abhinandan Rasayan

Kopran Limited, an Indian pharma company, said that its fully-owned subsidiary Kopran Research Laboratories Limited has purchased the assets of an API manufacturing facility of Abhinandan Rasayan located at MIDC – Ambernath in Maharashtra.

The acquisition is contingent on some terms and conditions as stated in the agreement.

According to the agreement, after the API manufacturing facility is made fully operational, it will help Kopran Research Laboratories in expanding its production capacity for APIs and intermediates.

See also  Biocon partners with Zentiva for European marketing of Liraglutide